ENDURANT CAPITAL MANAGEMENT LP – Fate Therapeutics, Inc. Transaction History
ENDURANT CAPITAL MANAGEMENT LP portfolio value:
$0
portfolio value
ENDURANT CAPITAL MANAGEMENT LP quarter portfolio value change:
-9.56%
quarter
Fate Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -71.64K shares | -1.77M | $22.41 | 0 |
| Q2 2022 | share | Increase | +19.94% | 11.90K shares | -541K | $24.78 | 71.64K |
| Q1 2022 | share | Increase | +60.03% | 22.40K shares | 132K | $38.77 | 59.73K |
| Q4 2021 | share | Increase | 0.00% | 37.32K shares | 2.18M | $60.07 | 37.32K |
| Q3 2021 | share | Decrease | -100.00% | -51.03K shares | -4.42M | $59.27 | 0 |
| Q2 2021 | share | Increase | +279.92% | 37.59K shares | 3.32M | $86.79 | 51.03K |
| Q1 2021 | share | Decrease | -79.83% | -53.15K shares | -4.94M | $82.45 | 13.43K |
| Q4 2020 | share | Increase | +18.46% | 10.37K shares | 3.80M | $90.93 | 66.58K |
| Q3 2020 | share | Decrease | -7.69% | -4.68K shares | 158K | $39.97 | 56.21K |
| Q2 2020 | share | Increase | +49.49% | 20.16K shares | 1.18M | $34.31 | 60.89K |
| Q1 2020 | share | Decrease | -69.83% | -94.29K shares | -1.73M | $22.21 | 40.73K |
| Q4 2019 | share | Decrease | -19.04% | -31.76K shares | 52K | $19.57 | 135.02K |
| Q3 2019 | share | Increase | 0.00% | 166.78K shares | 2.59M | $15.53 | 166.78K |
| Q4 2018 | share | Decrease | -100.00% | -204.33K shares | -3.32M | $12.83 | 0 |
| Q3 2018 | share | Increase | +147.46% | 121.76K shares | 2.39M | $16.29 | 204.33K |
| Q2 2018 | share | Decrease | -46.85% | -72.77K shares | -580K | $11.34 | 82.57K |
| Q1 2018 | share | Decrease | -72.09% | -401.33K shares | -1.88M | $9.76 | 155.34K |
| Q4 2017 | share | Increase | +104.14% | 283.97K shares | 2.32M | $6.11 | 556.67K |
| Q3 2017 | share | Increase | 0.00% | 272.7K shares | 1.08M | $3.96 | 272.7K |